Hydroxychloroquine: FDA revokes emergency use of malaria drug Trump promoted as coronavirus cure

Agency cites growing evidence of potentially deadly side effects despite president's claims

Chris Riotta
New York
Monday 15 June 2020 18:27
Comments
Fox News host warns Donald Trump about taking hydroxychloroquine: 'This will kill you'_1.mp4

The US Food and Drug Administration has revoked emergency use authorisations for anti-malaria drugs which President Donald Trump claimed without evidence could be used to treat Covid-19 as new research reveals potentially deadly side effects.

Drugs like hydroxychloroquine and chloroquine flew off the shelves in recent months after they were touted by the US president to treat and even prevent the disease caused by the novel coronavirus, which triggered a global pandemic after an outbreak in Wuhan, China at the end of last year.

Mr Trump previously revealed he was taking hydroxychloroquine, a drug that can be used to treat malaria and, in some cases, rheumatoid arthritis and other ailments, as part of an apparent effort to prevent himself from contracting the coronavirus.

In revoking emergency status for the drugs, the FDA cited a growing pool of evidence that showed potential health risks for Covid-19 patients. Doctors can still prescribe them as alternate medicines to patients under the updated guidelines.

Hydroxychlrooquine may cause nerve damage, heart rhythm problems and low blood pressure.

The president said last month that he was taking hydroxychloroquine, telling reporters: “All I can tell you is, so far, I feel okay.

“It seems to have an impact,” he said. “Maybe it does, maybe it doesn’t…You’re not going to get sick and die.”

The FDA previously reminded healthcare professionals and patients of the “known risks” associated with both hydroxychloroquine and chloroquine after the agency said it was “aware of reports of serious heart rhythm problems in patients with Covid-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines.”

Mr Trump said it White House medical team determined the “potential benefit outweighed the relative risks” of taking the drug as a preventative measure.

However, doctors who had prescribed the anti-malaria drugs were filling prescriptions for patients who had already contracted Covid-19, while Mr Trump was taking the drug as an alleged form of prevention.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in